| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.004 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |